Notice Number: NOT-OD-19-134

Key Dates
Release Date: August 13, 2019

Issued by
National Institutes of Health (NIH)

Purpose

This Notice informs potential applicants for a Mentored Patient-Oriented Research Career Development Award (K23) of the correct funding opportunity announcement (FOA) to use when proposing experimental studies involving humans, that is, studies that fall within the NIH definition of a clinical trial and also meet the definition of basic research.

Currently reads:

Prospective studies with humans conducted with specific applications towards processes or products in mind, including FDA Phase 0 or 1 studies, mechanistic clinical trials (e.g., those that examine the mechanisms by which an intervention works or the processes that account for an intervention's effects on clinical outcome), and safety and efficacy studies should submit under the parent PA-19-119, but not under this FOA.  

Modified to read (change in italics):

Prospective studies with humans conducted with specific applications towards processes or products in mind, including FDA Phase 0 or 1 studies, mechanistic clinical trials (e.g., those that examine the mechanisms by which an intervention works or the processes that account for an intervention's effects on clinical outcome), and safety and efficacy studies should submit under the parent PA-19-087, but not under this FOA.  

All other aspects of this FOA remains unchanged.

Inquiries

Please direct all inquiries to:

Division of Biomedical Research Workforce
Office of Extramural Research
Website: https://researchtraining.nih.gov 
Email: [email protected]